Table 5.
HIV prevalences in HIV indicator conditions stratified by age.
| HIV indicator condition | <30 years of age |
30–< 60 years of age |
From 60 years of age |
|||
|---|---|---|---|---|---|---|
| Sample size | HIV prevalence in % (95%-CI) | Sample size | HIV prevalence in % (95%-CI) | Sample size | HIV prevalence in % (95%-CI) | |
| Pneumocystosis | <50 | – | 314 | 63.38 (57.97–68.79) | 268 | 13.06 (8.96–17.16) |
| Oral hairy leukoplakia | <50 | – | 97 | 48.45 (38.14–58.76) | 57 | 15.79 (7.02–26.32) |
| Kaposi's sarcoma | <50 | – | 477 | 51.78 (47.18–56.18) | 497 | 9.26 (6.84–11.87) |
| Syphilis | 996 | 14.56 (12.35–16.77) | 5775 | 20.85 (19.83–21.9) | 6168 | 2.24 (1.88–2.61) |
| Gonococcal infection | 1885 | 4.3 (3.4–5.25) | 3248 | 10.13 (9.08–11.18) | 1172 | 2.22 (1.37–3.16) |
| Acute hepatitis C | 230 | 3.48 (1.3–6.09) | 6608 | 3.92 (3.45–4.4) | 2290 | 0.83 (0.48–1.22) |
| Malignant neoplasm of anus and anal canal | <50 | – | 1763 | 6.24 (5.1–7.37) | 3014 | 1 (0.66–1.36) |
| Chronic viral hepatitis | 470 | 1.91 (0.85–3.19) | 6811 | 3.7 (3.26–4.16) | 2339 | 0.9 (0.56–1.33) |
| Anogenital (venereal) warts | 1845 | 1.19 (0.7–1.73) | 3958 | 3.74 (3.16–4.32) | 458 | 1.97 (0.87–3.28) |
| Chlamydial infection | 3584 | 0.7 (0.45–0.98) | 2112 | 4.88 (3.98–5.82) | 324 | 2.16 (0.62–3.7) |
| Acute hepatitis B | 672 | 0.74 (0.15–1.49) | 6652 | 2.04 (1.71–2.39) | 2651 | 0.94 (0.6–1.32) |
| Papillomavirus as the cause of diseases | 1230 | 0.49 (0.16–0.89) | 2417 | 2.19 (1.61–2.81) | 240 | 2.08 (0.42–4.17) |
| Tuberculosis | 1430 | 0.84 (0.42–1.33) | 7841 | 2.88 (2.51–3.26) | 7836 | 0.38 (0.26–0.52) |
| Hodgkin's lymphoma | 805 | 0.25 (0–0.62) | 4005 | 1.87 (1.47–2.3) | 3171 | 0.41 (0.19–0.63) |
| Acute hepatitis A | 367 | 1.09 (0.27–2.18) | 4725 | 1.71 (1.35–2.1) | 3998 | 0.33 (0.15–0.53) |
| Pneumonia | 1576 | 0.82 (0.38–1.33) | 9181 | 1.87 (1.6–2.16) | 13,256 | 0.25 (0.17–0.34) |
| Non-Hodgkin's lymphoma | 619 | 0.48 (0–1.13) | 7330 | 1.3 (1.04–1.57) | 15,322 | 0.17 (0.1–0.23) |
| Infectious mononucleosis | 2942 | 0.27 (0.1–0.48) | 3164 | 0.57 (0.32–0.85) | 752 | 0.13 (0–0.4) |
| Herpes simplex infections | 1036 | 0.39 (0.1–0.77) | 3006 | 0.5 (0.27–0.77) | 1835 | 0.22 (0.05–0.44) |
| Abnormal weight loss | 550 | 0.18 (0–0.55) | 1705 | 0.82 (0.41–1.29) | 2007 | 0.05 (0–0.15) |
| Candidiasis | 1040 | 0 (0–0) | 2541 | 0.55 (0.28–0.87) | 1565 | 0.26 (0.06–0.51) |
| Herpes zoster | 312 | 0.64 (0–1.6) | 1713 | 0.76 (0.35–1.23) | 2610 | 0.04 (0–0.11) |
| Dysplasia/malignant neoplasm of cervix uteri | 2121 | 0.09 (0–0.24) | 8709 | 0.39 (0.26–0.53) | 3678 | 0.05 (0–0.14) |
| Trichomoniasis | 1696 | 0 (0–0) | 4021 | 0.4 (0.22–0.6) | 795 | 0.13 (0–0.38) |
| Malignant neoplasm of bronchus and lung | <50 | – | 655 | 0.61 (0.15–1.22) | 1798 | 0.11 (0–0.28) |
| Seborrheic dermatitis | 779 | 0.13 (0–0.39) | 2666 | 0.41 (0.19–0.68) | 2784 | 0.07 (0–0.18) |